Recent Updates
Recently added Catalysts
INFU

InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INVESTOR CONTACT: Pat LaVecchia Vice Chairman Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Thursday

Key Takeaway: InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Thursday, November 10, 2011 InfuSystem Holdings, Inc. Reports $14.5 Million of Revenues and $4.0 Million of Adjusted EBITDA for the Third Quarter of 2011. MADISON HEIGHTS, MICHIGAN

Full Press Release Details

InfuSystem Holdings, Inc.
31700 Research Park Drive
Madison Heights, MI 48071
248-291-1210
Thursday, November 10, 2011
InfuSystem Holdings, Inc. Reports $14.5 Million of Revenues and $4.0 Million of Adjusted
EBITDA for the Third Quarter of 2011.
MADISON HEIGHTS, MICHIGAN, November 10, 2011 InfuSystem Holdings, Inc. (NYSE Amex: INFU), the leading national provider of infusion pumps and related services, today reported results for the
third quarter ended September 30, 2011.
Revenues for the third quarter of fiscal 2011 were $14.5 million compared with $12.7 million
for the prior year, up 14 percent. Adjusted EBITDA for the third quarter of fiscal 2011 was $4.0 million, versus $3.9 million a year ago.
Mr. Sean McDevitt, Chief Executive Officer and Chairman, commented, We reported a solid performance this past quarter delivering 14% of almost
entirely organic growth over the same period last year. This was our sixteenth straight quarter of year over year revenue growth and a milestone in that our employees achieved the highest quarterly revenues in InfuSystem s 25 year history. On a
sequential quarter over quarter basis, we grew revenue over 10%. In regard to the oncology drug shortage, it continued to have a slight impact in the third quarter. The drug shortage s impact was offset through our stated strategy of
diversifying our revenue stream and business mix, while maintaining and strengthening our strong leadership in the consignment business by adding new customers.
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
Mr. McDevitt continued, InfuSystem remains committed to its core vision of becoming a
significant leader in the infusion and pre-owned medical equipment markets, increasing revenue, maintaining attractive EBITDA margins, generating substantial free cash flow, paying down debt, and improving our overall financial profile.
Additionally, our goal remains to achieve top line revenues of several hundred million dollars in our target markets over the next several years and additive, synergistic acquisitions will be a key part of that growth, Mr. McDevitt
Revenues for the third quarter ending September 30, 2011 were $14.5 million, up 14 percent from $12.7 million in the prior
year period. The increase in revenues is related to obtaining business at new customer facilities and expansion into new product lines associated with our acquisitions.
Gross profit for the three months ending September 30, 2011 was $9.2 million, up 4 percent from $8.9 million in the prior year period. Gross margins were 64 percent of revenues for the latest quarter
compared with 70 percent in the prior year period. The decrease in the gross margin percentage was primarily related to a higher mix of pump sales, services, and rentals as compared to third party billings.
Selling, general and administrative expenses (SG&A) for the third quarter of 2011 were $8.3 million, excluding a goodwill and intangible assets
impairment charge of $23.4 million, 3 percent higher than the $8.1 million in the prior year period. The increase was due to strategic investments made in the sales organization, such as the launch of our iPad-based electronic paperwork system,
amortization of intangibles, and professional fees. These expenses were partially offset by the decreases in stock based compensation and bad debt expenses. As a percent of revenues, SG&A was 58 percent compared to 63 percent for the prior
As of September 30, 2011, the company determined that given the significant decline in our market capitalization that there was
an indicator to require an interim goodwill impairment analysis. Based upon the impairment analysis performed as of September 30, 2011, the company concluded there was an impairment of the remaining goodwill that resulted in a non-cash charge
Other loss for the third quarter of 2011 was $0.7 million versus $0.4 million other loss in the prior year period,
reflecting reduced interest expense and no gain on derivatives as incurred in the prior year. The provision for income taxes was a benefit of $6.5 million for the quarter compared to an expense of $295 thousand in the prior year period. As a result,
the second quarter net loss was $16.6 million, driven by the non-cash goodwill impairment charge, equal to $0.79 per diluted share, versus a $174 thousand net income, equal to $0.01 per diluted share in the prior year period.
Adjusted EBITDA was $4.0 million for the third quarter of 2011 versus $3.9 million in the prior year period. The company utilizes Adjusted EBITDA as a
means to measure its operating performance. A reconciliation of Adjusted EBITDA, a non-GAAP measure, to net income can be found in the appendix.
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
Net cash provided by operations for the nine months ending September 30, 2011 was $4.2 million, compared to $7.8 million for the prior period. Principal and interest payments of $2.0 million, on our
term loan and capital leases, were paid during the quarter. The company ended the quarter with a cash balance of $0.4 million with $23.8 million in long-term debt, net of current.
InfuSystem Holdings, Inc. will host a conference call to share the results
of its third quarter fiscal 2011 results on Thursday, November 10, at 10:00 a.m. Eastern Time. Chairman and Chief Executive Officer Sean McDevitt and Jim Froisland, Chief Financial Officer, will discuss the company s financial performance
and answer questions from the financial community.
The company invites interested investors to listen to the presentation, which will be
carried live on the company s Web site: www.infusystem.com in the Investors section. To participate by telephone, the dial-in number is 800-447-0521 with confirmation number 30770688. Those who wish to listen should either dial in or go
to the web site several minutes prior to the call to register. A replay of the call can be accessed by dialing 888-843-7419, passcode 30770688#. An online archive of the conference call will remain on the company s website for the following 30
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison
Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company s stock is traded on the NYSE Amex under the symbol INFU.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and
uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the
company s publicly filed documents.
Additional information about InfuSystem Holdings, Inc. is available at
FINANCIAL TABLES FOLLOW
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data) September 30, 2011 December 31, 2010
(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents $ 433 $ 5,014
Accounts receivable, less allowance for doubtful accounts of $1,719 and $1,796 at September 30, 2011 and December 31, 2010, respectively 7,983 6,679
Inventory 2,155 1,699
Prepaid expenses and other current assets 736 750
Deferred income taxes 1,249 1,147
Total Current Assets 12,556 15,289
Property & equipment, net 16,883 16,672
Deferred debt issuance costs, net 477 658
Goodwill 64,092
Intangible assets, net 28,683 33,252
Deferred income taxes 20,135
Other assets 758 401
Total Assets $ 79,492 $ 130,364
LIABILITIES AND STOCKHOLDERS EQUITY
Current Liabilities:
Accounts payable $ 1,945 $ 2,016
Other current liabilities 2,061 4,631
Derivative liabilities 302 183
Current portion of long-term debt 6,465 5,551
Total Current Liabilities 10,773 12,381
Long-term debt, net of current portion 23,783 26,646
Deferred income taxes 3,250 5,788
Other liabilities 965 406
Total Liabilities $ 38,771 $ 45,221
Stockholders Equity
Preferred stock, $.0001 par value: authorized 1,000,000 shares; none issued
Common stock, $.0001 par value; authorized 200,000,000 shares; issued 21,244,916 and 21,163,337, respectively; outstanding 21,048,076 and 21,117,516, respectively 1 2
Additional paid-in capital 87,362 87,004
Accumulated other comprehensive loss (165 ) (64 )
Retained deficit (46,477 ) (1,799 )
Total Stockholders Equity $ 40,721 $ 85,143
Total Liabilities and Stockholders Equity $ 79,492 $ 130,364
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended September 30 Nine Months Ended September 30
(in thousands, except share data) 2011 2010 2011 2010
Net revenues $ 14,505 $ 12,733 $ 40,595 $ 34,154
Cost of revenues:
Cost of revenues Product, service and supply costs 2,346 2,130 6,662 5,524
Cost of revenues Pump depreciation, sales and disposals 2,927 1,706 6,659 4,094
Gross profit 9,232 8,897 27,274 24,536
Selling, general and administrative expenses:
Provision for doubtful accounts 884 986 3,033 3,454
Amortization of intangibles 683 624 1,992 1,615
Asset impairment charges 23,379 67,592
Selling and marketing 2,320 1,702 7,089 4,739
General and administrative 4,460 4,757 13,227 12,662
Total sales, general and administrative: 31,726 8,069 92,933 22,470
Operating (loss) income (22,494 ) 828 (65,659 ) 2,066
Other loss:
Gain (loss) on derivatives 250 83 (210 )
Interest expense (541 ) (609 ) (1,646 ) (2,781 )
Gain on extinguishment of long term debt 1,118
Other income (118 ) (118 )
Total other loss (659 ) (359 ) (1,681 ) (1,873 )
(Loss) before income taxes (23,153 ) 469 (67,340 ) 193
Income tax benefit (expense) 6,530 (295 ) 22,661 112
Net (loss) income $ (16,623 ) $ 174 $ (44,679 ) $ 305
Net (loss) income per share:
Basic $ (0.79 ) $ 0.01 $ (2.12 ) $ 0.02
Diluted $ (0.79 ) $ 0.01 $ (2.12 ) $ 0.01
Weighted average shares outstanding:
Basic 21,067,502 19,904,648 21,076,241 19,539,326
Diluted 21,067,502 21,647,904 21,076,241 20,742,765
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended September 30
(in thousands) 2011 2010
OPERATING ACTIVITIES
Net (loss) income $ (44,679 ) $ 305
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
(Gain) loss on derivative liabilities (84 ) 210
Gain on extinguishment of long-term debt (1,118 )
Provision for doubtful accounts 3,033 3,454
Depreciation 4,890 3,869
Net book value of pumps sold from fixed assets 2,111 510
Amortization of intangible assets 1,992 1,615
Asset impairment charges 67,592
Amortization of deferred debt issuance costs 181 915
Stock-based compensation 921 1,811
Deferred income taxes (22,673 ) (519 )
Changes in assets and liabilities, exclusive of effects of acquisitions:
Increase in accounts receivable, net of provision (4,337 ) (3,556 )
Increase in other current assets (442 ) (89 )
(Increase) decrease in other assets (70 ) 170
(Decrease) increase in accounts payable and other liabilities (4,187 ) 553
Decrease in derivative liabilities from termination of interest rate swap (365 )
NET CASH PROVIDED BY OPERATING ACTIVITIES 4,248 7,765
INVESTING ACTIVITIES
Capital expenditures (3,295 ) (992 )
Acquisition of intangible assets (942 ) (400 )
Cash paid for acquisition, net of cash acquired (16,418 )
NET CASH (USED IN) INVESTING ACTIVITIES (4,237 ) (17,810 )
FINANCING ACTIVITIES
Principal payments on term loan (3,287 ) (21,596 )
Cash proceeds from term loan 30,000
Capitalized debt issuance costs (808 )
Common stock repurchased to satisfy statutory withholding on stock based compensation (38 )
Treasury shares repurchased (343 )
Principal payments on capital lease obligations (962 ) (571 )
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (4,592 ) 6,987
Net change in cash and cash equivalents (4,581 ) (3,058 )
Cash and cash equivalents, beginning of period 5,014 7,750
Cash and cash equivalents, end of period $ 433 $ 4,692
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2011 Results
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES
Three Months Ended September 30 Nine Months Ended September 30
(in thousands, except share data) 2011 2010 2011 2010
Net (loss) income $ (16,623 ) $ 174 $ (44,679 ) $ 305
Adjustments:
Interest expense 541 609 1,646 2,781
Income tax (benefit) expense (6,530 ) 295 (22,661 ) (112 )
Depreciation 1,721 1,487 4,890 3,869
Amortization 683 624 1,992 1,615
EBITDA (20,208 ) 3,189 (58,812 ) 8,458
Adjustments:
Asset impairment charges 23,379 67,592
(Gain) loss on derivatives (250 ) (83 ) 210
Stock based compensation 420 814 921 1,811
Sales and other incentives 699
Acquisition related expenses 396 180 643 965
Severance 65
Gain on debt extinguishment (1,118 )
Adjusted EBITDA $ 3,987 $ 3,933 $ 11,025 $ 10,326
Last updated: Nov 10, 2011